The global prosthetic heart valve market share is estimated to register a strong CAGR of 12.0% over the forecast period and exceed a market valuation of US$ 19.60 Billion by the end of 2026.
According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.
Prosthetic Heart Valve Market Key Segmentation:
By Product Type
Mechanical Heart Valves
Mechanical Aortic Valve
Mechanical Mitral Valve
Biological/Tissue Heart Valves
Tissue Aortic Valve
Tissue Mitral Valve
Transcatheter Heart Valves
Transcatheter Aortic Valve
Transcatheter Mitral Valve
By End User
Hospitals
Ambulatory Surgery Centres
By Region
North America
Latin America Excluding Brazil
Brazil
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Middle East & Africa (MEA)
Segmental Forecast:
The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% ****ween 2016 and 2026
The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period
Regional Market Overview:
The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.
The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.
Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for ****ter care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.
Competitive Landscape:
The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are –
Edwards Lifesciences Corporation
St. Jude Medical, Inc.
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
SYMETIS
LivaNova PLC
CryoLife, Inc.
Braile Biomedica
Colibri Heart Valve LLC
JenaValve Technology, Inc.
Leading market players are focusing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.
Key strategies adopted by most of the major players in the global prosthetic heart valve market include: product approvals and commercialization, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.
For more Information @ https://www.futuremarketinsigh....ts.com/reports/prost
